Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Neus, Baste"'
Autor:
Sara I. Pai, Ezra E. W. Cohen, Derrick Lin, George Fountzilas, Edward S. Kim, Holger Mehlhorn, Neus Baste, Daniel Clayburgh, Loren Lipworth, Carlo Resteghini, Nawar Shara, Takashi Fujii, Jun Zhang, Michael Stokes, Huifen Wang, Philip Twumasi-Ankrah, Sophie Wildsmith, Asud Khaliq, Giovanni Melillo, Norah Shire
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-14 (2019)
Abstract Background Programmed cell death ligand-1 (PD-L1) expression on tumor cells (TCs) is associated with improved survival in patients with head and neck squamous cell carcinoma (HNSCC) treated with immunotherapy, although its role as a prognost
Externí odkaz:
https://doaj.org/article/a6cc8d6715dd481d84183933b4c912f5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Neus Baste
Publikováno v:
Cancer Medicine. 11:10-16
In this article, we focus on a variety of immunosuppression scenarios and whether multikinase inhibitors, as systemic therapy for advanced thyroid carcinoma (TC), could be useful for the treatment of immunocompromised patients with TC. Lenvatinib and
Autor:
Alfredo Páez-Carpio, Santiago Medrano-Martorell, Joan Berenguer, Africa Muxí, Isabel Vilaseca, Izaskun Valduvieco, Paola Castillo, Neus Baste, F. Xavier Avilés-Jurado, Juan José Grau, Laura Oleaga
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 280:1369-1379
To identify response predictors in patients with head and neck squamous cell carcinoma (N + HNSCC) and persistent lymph nodes after curative chemoradiotherapy treatment (CCRT).Consecutive patients with N + HNSCC treated with CCRT and persistent lymph
Publikováno v:
Endocrine Abstracts.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Edith Borcoman, Christophe Le Tourneau, Grégoire Vuagniaux, Sébastien Vergez, Jérôme Sarini, Neus Baste, Philippe Rochaix, Franck Brichory, Annick Menetrey, Stéphane Temam, Claudio Zanna, Elisabeth Rouits, Carlos Gomez-Roca, Jean-Pierre Delord, Daniela Purcea, Caroline Hoffmann, Caroline Even, Bruno Gavillet
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 1, Pp 55-62 (2022)
Clinical and Translational Science
Clinical and Translational Science
Inhibitor of apoptosis proteins (IAPs) regulate apoptosis and modulate NF‐κB signaling thereby driving expression of genes involved in immune/inflammatory responses. The orally available IAP antagonist Debio 1143 has potential to enhance tumor res
Autor:
F.R. Ferrand, Khalil Saleh, Anne Auperin, Edith Borcoman, Amaury Daste, Christophe Le Tourneau, M. Iacob, Neus Baste, Nicolas Martin, Nadine Khalife, Caroline Even, Esma Saada-Bouzid, Nouritza Torossian, Joël Guigay
Publikováno v:
European Journal of Cancer. 157:190-197
Background Recent meta-analysis showed that immune checkpoint inhibitors (ICIs) have comparable activity between younger and older patients. However, little is known about efficacy and safety of ICI in elderly patients with relapsed/metastatic squamo
Autor:
Isabel, Vilaseca, Francesc, Xavier Avilés-Jurado, Eduardo, Lehrer, Izaskun, Valduvieco, Neus, Baste, Rosa, Delia Ramírez, José, Miguel Costa, Santiago, Medrano-Martorell, África, Muxí, Paola, Castillo, Llúcia, Alós, Manuel, Bernal-Sprekelsen
Publikováno v:
Oral oncology. 134
COTo evaluate the complications and the oncologic and functional outcomes of CORetrospective analysis of 1244 consecutive laryngeal carcinomas treated with COThe mean age was 64.2 ± 11.1 years (20-96). Four hundred and sixteen patients were older th
Publikováno v:
Current Opinion in Oncology. 33:184-195
Purpose of review We review the new systemic treatment strategies for differentiated thyroid carcinoma, as well as the acquaintance of its molecular biology. Recent findings Multiple kinase inhibitor drugs have become the standard therapy for thyroid